About this trial
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
presence of immediate postoperative CBCT,
initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
thin intact labial bone plate (< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
Disqualifiers
patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
patients with active infection related at the site of implant and patients with untreated active periodontal diseases.
Trial population
All patients were treated with flapless immediate implants with no grafting procedures in the esthetic zone.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Pink esthetic score
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: